Company |
Drug |
Indication |
Antares Pharma Inc. |
Oxybutynin gel |
Overactive bladder with symptoms of urge urinary incontinence, urgency and frequency |
Endo Pharmaceuticals Holdings Inc. |
Opana ER |
A crush-resistant formulation for pain |
Merck & Co. Inc. |
Isentress |
For use with other antiretroviral drugs to treat HIV in children and adolescents age 2-18 |
ViroPharma Inc. |
Vancocin |
Modern label, adding clinical safety and efficacy data to treat currently circulating strains of Clostridium difficile infection |